{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:53:51Z","timestamp":1792180431897,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":681,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41379-020-0645-6","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T12:04:09Z","timestamp":1596801849000},"page":"647-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8618-7691","authenticated-orcid":false,"given":"Thomas","family":"Denize","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Alexandre","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Sibony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Blons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Olivier","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Drossart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Jakubowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Broudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Morini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Vano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Auvray-Kuentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Mejean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4816-670X","authenticated-orcid":false,"given":"Anne Paule","family":"Gimenez Roqueplo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Burnichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Verkarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0645-6_bib1","doi-asserted-by":"crossref","unstructured":"Moch H, Humphrey P, Ulbright T, Reuter V. WHO classification of tumours of the urinary system and male genital organs. 4th ed. Lyon: IARC Press; 2016.","DOI":"10.1016\/j.eururo.2016.02.028"},{"key":"10.1038\/s41379-020-0645-6_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.anndiagpath.2012.08.007","article-title":"Biphasic alveolosquamoid renal carcinoma: a histomorphological, immunohistochemical, molecular genetic, and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma","volume":"16","author":"Petersson","year":"2012","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-020-0645-6_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pin.12844","article-title":"Biphasic squamoid alveolar renal carcinoma with positive CD57 expression: a clinicopathologic study of three cases","volume":"69","author":"Zhou","year":"2019","journal-title":"Pathol Int."},{"key":"10.1038\/s41379-020-0645-6_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.humpath.2016.06.018","article-title":"Renal cell carcinoma in kidney allografts: histologic types, including biphasic papillary carcinoma","volume":"57","author":"Troxell","year":"2016","journal-title":"Hum Pathol."},{"key":"10.1038\/s41379-020-0645-6_bib5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/PAS.0000000000000639","article-title":"Biphasic squamoid alveolar renal cell carcinoma","volume":"40","author":"Hes","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0645-6_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/his.13432","article-title":"Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases","volume":"72","author":"Trpkov","year":"2018","journal-title":"Histopathology."},{"key":"10.1038\/s41379-020-0645-6_bib7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/PAS.0000000000000870","article-title":"Biphasic squamoid alveolar renal cell carcinoma: 2 cases in a family supporting a continuous spectrum with papillary type I renal cell carcinoma","volume":"41","author":"Chartier","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0645-6_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.12688\/f1000research.8451.1","article-title":"Case report: multifocal biphasic squamoid alveolar renal cell carcinoma","volume":"5","author":"L\u00f3pez","year":"2016","journal-title":"F1000Research"},{"key":"10.1038\/s41379-020-0645-6_bib9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00000478-199710000-00011","article-title":"Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features","volume":"21","author":"Renshaw","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0645-6_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/his.12106","article-title":"Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive features","volume":"62","author":"Mantoan Padilha","year":"2013","journal-title":"Histopathology."},{"key":"10.1038\/s41379-020-0645-6_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.anndiagpath.2016.04.008","article-title":"Solid papillary renal cell carcinoma: clinicopathologic, morphologic, and immunohistochemical analysis of 10 cases and review of the literature","volume":"23","author":"Ulamec","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-020-0645-6_bib12","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-08-1229","article-title":"Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma","volume":"15","author":"Klatte","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0645-6_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.anndiagpath.2017.11.004","article-title":"Chromosomal numerical aberration pattern in papillary renal cell carcinoma: review article","volume":"40","author":"Pitra","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-020-0645-6_bib14","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"Cohen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-0645-6_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2019.06.015","article-title":"Familial kidney cancer: implications of new syndromes and molecular insights","volume":"76","author":"Carlo","year":"2019","journal-title":"Eur Urol."},{"key":"10.1038\/s41379-020-0645-6_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.annpat.2020.02.022","article-title":"Hereditary kidney cancers: the pathologist's view in 2020","volume":"40","author":"Verkarre","year":"2020","journal-title":"Ann Pathol."},{"key":"10.1038\/s41379-020-0645-6_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet."},{"key":"10.1038\/s41379-020-0645-6_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"The Cancer Genome Atlas Research Network.","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-0645-6_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng.3146","article-title":"Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes","volume":"47","author":"Durinck","year":"2015","journal-title":"Nat Genet."},{"key":"10.1038\/s41379-020-0645-6_bib20","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1158\/1078-0432.CCR-13-2173","article-title":"MET Is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array","volume":"20","author":"Albiges","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0645-6_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.eururo.2017.05.033","article-title":"Characterization of clinical cases of advanced papillary renal cell carcinoma via comprehensive genomic profiling","volume":"73","author":"Pal","year":"2018","journal-title":"Eur Urol."},{"key":"10.1038\/s41379-020-0645-6_bib22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.onc.1201983","article-title":"Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours","volume":"17","author":"Fischer","year":"1998","journal-title":"Oncogene."},{"key":"10.1038\/s41379-020-0645-6_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/1727","article-title":"Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas","volume":"20","author":"Zhuang","year":"1998","journal-title":"Nat Genet."},{"key":"10.1038\/s41379-020-0645-6_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-5049-3","article-title":"Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review","volume":"18","author":"Rochigneux","year":"2018","journal-title":"BMC Cancer."},{"key":"10.1038\/s41379-020-0645-6_bib25","doi-asserted-by":"crossref","first-page":"103428","DOI":"10.18632\/oncotarget.21952","article-title":"Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression","volume":"8","author":"Lalani","year":"2017","journal-title":"Oncotarget."},{"key":"10.1038\/s41379-020-0645-6_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/0973-029X.203763","article-title":"Emperipolesis, entosis and cell cannibalism: demystifying the cloud","volume":"21","author":"Gupta","year":"2017","journal-title":"J Oral Maxillofac Pathol"},{"key":"10.1038\/s41379-020-0645-6_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.humpath.2013.10.033","article-title":"Clear cell renal cell carcinoma with a syncytial-type multinucleated giant tumor cell component: Implications for differential diagnosis","volume":"45","author":"Williamson","year":"2014","journal-title":"Hum Pathol."},{"key":"10.1038\/s41379-020-0645-6_bib28","first-page":"277","article-title":"High-grade renal cell carcinoma with emperipolesis: clinicopathological, immunohistochemical and molecular-genetic analysis of 14 cases","volume":"33","author":"Rotterova","year":"2018","journal-title":"Histol Histopathol."},{"key":"10.1038\/s41379-020-0645-6_bib29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAS.0000000000000906","article-title":"The squamoid cells in biphasic squamoid alveolar renal carcinoma present cytophagocytosis (not emperipolesis) of apoptotic neutrophilic granulocytes","volume":"42","author":"Su\u00e1rez-Vilela","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0645-6_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.urology.2006.09.052","article-title":"Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification","volume":"69","author":"Pignot","year":"2007","journal-title":"Urology."},{"key":"10.1038\/s41379-020-0645-6_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0143468","article-title":"Relationships between chromosome 7 gain, MET gene copy number increase and MET protein overexpression in Chinese papillary renal cell carcinoma patients","volume":"10","author":"Yin","year":"2015","journal-title":"PLoS ONE."},{"key":"10.1038\/s41379-020-0645-6_bib32","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/01.MP.0000090924.90762.94","article-title":"Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study","volume":"16","author":"Brunelli","year":"2003","journal-title":"Mod Pathol."},{"key":"10.1038\/s41379-020-0645-6_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.01566","article-title":"Case of hereditary papillary renal cell carcinoma type I in a patient with a germline MET mutation in Russia","volume":"9","author":"Mikhaylenko","year":"2020","journal-title":"Front Oncol."},{"key":"10.1038\/s41379-020-0645-6_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejca.2017.10.014","article-title":"Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial","volume":"87","author":"Sch\u00f6ffski","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-020-0645-6_bib35","unstructured":"cBioPortal for Cancer Genomics. https:\/\/www.cbioportal.org\/study\/summary?id=kirp_tcga."},{"key":"10.1038\/s41379-020-0645-6_bib36","first-page":"1392","article-title":"Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features","volume":"6","author":"Xia","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/s41379-020-0645-6_bib37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3346\/jkms.2006.21.4.672","article-title":"MET expression in sporadic renal cell carcinomas","volume":"21","author":"Choi","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1038\/s41379-020-0645-6_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.clgc.2017.01.021","article-title":"Correlation of c-Met expression and outcome in patients with renal cell carcinoma treated with sunitinib","volume":"15","author":"Peltola","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1038\/s41379-020-0645-6_bib39","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1200\/JCO.2017.72.2967","article-title":"Biomarker-based phase II trial of savolitinib in patients with advanced papillary renal cell cancer","volume":"35","author":"Choueiri","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0645-6_bib40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejca.2018.08.014","article-title":"Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: a retrospective analysis","volume":"104","author":"Campbell","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-020-0645-6_bib41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1470-2045(18)30907-0","article-title":"Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study","volume":"20","author":"Mart\u00ednez Chanz\u00e1","year":"2019","journal-title":"Lancet Oncol."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-0645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-0645-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-0645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:38:45Z","timestamp":1760229525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222006640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0893395222006640"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0645-6","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0645-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}